Cargando…
Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Background and objectives: Induction chemotherapy (ICT) before definitive chemoradiation (CRT) gives high response rates in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). However, pre-ICT gross tumor volume (GTV) for radiotherapy (RT) planning is still recommended. As (18)...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306774/ https://www.ncbi.nlm.nih.gov/pubmed/30544718 http://dx.doi.org/10.3390/medicina54060107 |
_version_ | 1783382854121553920 |
---|---|
author | Rudžianskas, Viktoras Korobeinikova, Erika Rudžianskienė, Milda Jaselskė, Evelina Adlienė, Diana Šedienė, Severina Kulakienė, Ilona Padervinskis, Evaldas Jurkienė, Nemira Juozaitytė, Elona |
author_facet | Rudžianskas, Viktoras Korobeinikova, Erika Rudžianskienė, Milda Jaselskė, Evelina Adlienė, Diana Šedienė, Severina Kulakienė, Ilona Padervinskis, Evaldas Jurkienė, Nemira Juozaitytė, Elona |
author_sort | Rudžianskas, Viktoras |
collection | PubMed |
description | Background and objectives: Induction chemotherapy (ICT) before definitive chemoradiation (CRT) gives high response rates in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). However, pre-ICT gross tumor volume (GTV) for radiotherapy (RT) planning is still recommended. As (18)F-FDG PET/CT has an advantage of biological tumor information comparing to standard imaging methods, we aimed to evaluate the feasibility of (18)F-FDG PET/CT-based post-ICT GTV delineation for RT planning in LA-SCCHN and to assess the prognostic value of PET parameters: maximum standardized uptake value (SUV(max)), metabolic tumor volume (MTV) and total lesion glycolysis (TLG). Methods: 47 LA-SCCHN patients were treated with 3 cycles of ICT (docetaxel, cisplatin, and 5-fluorouracil) followed by CRT (70 Gy in 35 fractions with weekly cisplatin). Pre- and post-ICT PET/CT examinations were acquired. Planning CT was co-registered with post-ICT PET/CT and RT target volumes were contoured according to post-ICT PET. Post-ICT percentage decrease of SUV(max), MTV and TLG in primary tumor and metastatic regional lymphnodes (LN) was counted. Loco-regional failure patterns, 3-year progression free (PFS) and overall survival (OS) were evaluated. Results: 3-year PFS and OS rates for study population were 67% and 61% respectively. 31.9% of patients progressed loco-regionally. All progress was localized in high-to-intermediate dose (60–70 Gy) RT volumes and none in low dose (50 Gy) volumes. Decrease of SUV(max) ≥ 74% (p = 0.04), MTV ≥ 68% (p = 0.03), TLG ≥ 76% (p = 0.03) in primary tumor, and LN TLG decrease ≥ 74% (p = 0.03) were associated with PFS. Decrease of primary tumor SUV(max) ≥ 74% (p = 0.04), MTV ≥ 69% (p = 0.03), TLG ≥ 74% (p = 0.02) and LN TLG ≥ 73% (p = 0.02) were prognostic factors for OS. Conclusions: According to our results, (18)F-FDG PET/CT-based post-ICT GTV delineation is feasible strategy without negative impacts on loco-regional control and survival. Percentage decrease of metabolic PET parameters SUV(max), MTV and TLG has a prognostic value in LA-SCCHN. |
format | Online Article Text |
id | pubmed-6306774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63067742019-01-02 Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck Rudžianskas, Viktoras Korobeinikova, Erika Rudžianskienė, Milda Jaselskė, Evelina Adlienė, Diana Šedienė, Severina Kulakienė, Ilona Padervinskis, Evaldas Jurkienė, Nemira Juozaitytė, Elona Medicina (Kaunas) Article Background and objectives: Induction chemotherapy (ICT) before definitive chemoradiation (CRT) gives high response rates in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). However, pre-ICT gross tumor volume (GTV) for radiotherapy (RT) planning is still recommended. As (18)F-FDG PET/CT has an advantage of biological tumor information comparing to standard imaging methods, we aimed to evaluate the feasibility of (18)F-FDG PET/CT-based post-ICT GTV delineation for RT planning in LA-SCCHN and to assess the prognostic value of PET parameters: maximum standardized uptake value (SUV(max)), metabolic tumor volume (MTV) and total lesion glycolysis (TLG). Methods: 47 LA-SCCHN patients were treated with 3 cycles of ICT (docetaxel, cisplatin, and 5-fluorouracil) followed by CRT (70 Gy in 35 fractions with weekly cisplatin). Pre- and post-ICT PET/CT examinations were acquired. Planning CT was co-registered with post-ICT PET/CT and RT target volumes were contoured according to post-ICT PET. Post-ICT percentage decrease of SUV(max), MTV and TLG in primary tumor and metastatic regional lymphnodes (LN) was counted. Loco-regional failure patterns, 3-year progression free (PFS) and overall survival (OS) were evaluated. Results: 3-year PFS and OS rates for study population were 67% and 61% respectively. 31.9% of patients progressed loco-regionally. All progress was localized in high-to-intermediate dose (60–70 Gy) RT volumes and none in low dose (50 Gy) volumes. Decrease of SUV(max) ≥ 74% (p = 0.04), MTV ≥ 68% (p = 0.03), TLG ≥ 76% (p = 0.03) in primary tumor, and LN TLG decrease ≥ 74% (p = 0.03) were associated with PFS. Decrease of primary tumor SUV(max) ≥ 74% (p = 0.04), MTV ≥ 69% (p = 0.03), TLG ≥ 74% (p = 0.02) and LN TLG ≥ 73% (p = 0.02) were prognostic factors for OS. Conclusions: According to our results, (18)F-FDG PET/CT-based post-ICT GTV delineation is feasible strategy without negative impacts on loco-regional control and survival. Percentage decrease of metabolic PET parameters SUV(max), MTV and TLG has a prognostic value in LA-SCCHN. MDPI 2018-12-10 /pmc/articles/PMC6306774/ /pubmed/30544718 http://dx.doi.org/10.3390/medicina54060107 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rudžianskas, Viktoras Korobeinikova, Erika Rudžianskienė, Milda Jaselskė, Evelina Adlienė, Diana Šedienė, Severina Kulakienė, Ilona Padervinskis, Evaldas Jurkienė, Nemira Juozaitytė, Elona Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
title | Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
title_full | Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
title_fullStr | Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
title_full_unstemmed | Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
title_short | Use of 18F-FDG PET/CT Imaging for Radiotherapy Target Volume Delineation after Induction Chemotherapy and for Prognosis of Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
title_sort | use of 18f-fdg pet/ct imaging for radiotherapy target volume delineation after induction chemotherapy and for prognosis of locally advanced squamous cell carcinoma of the head and neck |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306774/ https://www.ncbi.nlm.nih.gov/pubmed/30544718 http://dx.doi.org/10.3390/medicina54060107 |
work_keys_str_mv | AT rudzianskasviktoras useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT korobeinikovaerika useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT rudzianskienemilda useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT jaselskeevelina useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT adlienediana useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT sedieneseverina useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT kulakieneilona useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT padervinskisevaldas useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT jurkienenemira useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck AT juozaityteelona useof18ffdgpetctimagingforradiotherapytargetvolumedelineationafterinductionchemotherapyandforprognosisoflocallyadvancedsquamouscellcarcinomaoftheheadandneck |